Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wasserman

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The American Journal of Bioethics : AJOB|May 14, 2023
A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials: Response to CommentariesSaskia Hendriks, Christine Grady, David Wasserman, et al.
Prenatal Diagnosis|May 4, 2022
A new ethical framework to determine acceptable risks in fetal therapy trialsSaskia Hendriks, Christine Grady, David Wasserman, et al.
The American Journal of Bioethics : AJOB|January 18, 2021
A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy TrialsSaskia Hendriks, Christine Grady, David Wasserman, et al.
Prenatal Diagnosis|November 19, 2016
Views of American OB/GYNs on the ethics of prenatal whole-genome sequencingMichelle J Bayefsky, Amina White, Paul Wakim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2010
Dependence on a retinophilin/myosin complex for stability of PKC and INAD and termination of phototransductionKartik Venkatachalam, David Wasserman, Xiaoyue Wang, et al.
Cardiovascular Diabetology|July 13, 2022
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonistBrett E Phillips, Louise Lantier, Carl Engman, et al.
Prenatal Diagnosis|December 9, 2023
Precarious hope: Ethical considerations for offering experimental fetal therapies outside of research after initial studies in humansSaskia Hendriks, Janyne Althaus, Meredith A Atkinson, et al.
Journal of Genetic Counseling|November 18, 2014
Disclosing Genetic Information to Family Members About Inherited Cardiac Arrhythmias: An Obligation or a Choice?Rick D Vavolizza, Isha Kalia, Kathleen Erskine Aaron, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 24, 2013
Clinical utility of chromosomal microarray analysis in prenatal diagnosis: report of first 6 months in clinical practiceSusan Klugman, Barrie Suskin, Brianna L Spencer, et al.
Qualitative Health Research|August 13, 2014
Translating advances in cardiogenetics into effective clinical practiceLouise Bordeaux Silverstein, Marina Stolerman, Nadia Hidayatallah, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The American Journal of Bioethics : AJOB|May 14, 2023
A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials: Response to CommentariesSaskia Hendriks, Christine Grady, David Wasserman, et al.
Prenatal Diagnosis|May 4, 2022
A new ethical framework to determine acceptable risks in fetal therapy trialsSaskia Hendriks, Christine Grady, David Wasserman, et al.
The American Journal of Bioethics : AJOB|January 18, 2021
A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy TrialsSaskia Hendriks, Christine Grady, David Wasserman, et al.
Prenatal Diagnosis|November 19, 2016
Views of American OB/GYNs on the ethics of prenatal whole-genome sequencingMichelle J Bayefsky, Amina White, Paul Wakim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2010
Dependence on a retinophilin/myosin complex for stability of PKC and INAD and termination of phototransductionKartik Venkatachalam, David Wasserman, Xiaoyue Wang, et al.
Cardiovascular Diabetology|July 13, 2022
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonistBrett E Phillips, Louise Lantier, Carl Engman, et al.
Prenatal Diagnosis|December 9, 2023
Precarious hope: Ethical considerations for offering experimental fetal therapies outside of research after initial studies in humansSaskia Hendriks, Janyne Althaus, Meredith A Atkinson, et al.
Journal of Genetic Counseling|November 18, 2014
Disclosing Genetic Information to Family Members About Inherited Cardiac Arrhythmias: An Obligation or a Choice?Rick D Vavolizza, Isha Kalia, Kathleen Erskine Aaron, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|October 24, 2013
Clinical utility of chromosomal microarray analysis in prenatal diagnosis: report of first 6 months in clinical practiceSusan Klugman, Barrie Suskin, Brianna L Spencer, et al.
Qualitative Health Research|August 13, 2014
Translating advances in cardiogenetics into effective clinical practiceLouise Bordeaux Silverstein, Marina Stolerman, Nadia Hidayatallah, et al.
Pageof 8